Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 318

2.

Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses.

Newcomer JW.

J Clin Psychiatry. 2009;70 Suppl 3:30-6. doi: 10.4088/JCP.7075su1c.05. Review.

3.

Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists.

Goff DC, Cather C, Evins AE, Henderson DC, Freudenreich O, Copeland PM, Bierer M, Duckworth K, Sacks FM.

J Clin Psychiatry. 2005 Feb;66(2):183-94; quiz 147, 273-4. Review.

PMID:
15705003
4.

Metabolic syndrome and mental illness.

Newcomer JW.

Am J Manag Care. 2007 Nov;13(7 Suppl):S170-7. Review. Erratum in: Am J Manag Care. 2008 Feb;14(2):76.

5.

Risk of cardiovascular disease and sudden death in schizophrenia.

Davidson M.

J Clin Psychiatry. 2002;63 Suppl 9:5-11. Review. Erratum in: J Clin Psychiatry 2002 Aug;63(8):744.

6.

Metabolism, lifestyle and bipolar affective disorder.

Morriss R, Mohammed FA.

J Psychopharmacol. 2005 Nov;19(6 Suppl):94-101. Review.

PMID:
16280342
7.

The comorbidity of diabetes mellitus and psychiatric disorders.

Medved V, Jovanović N, Knapić VP.

Psychiatr Danub. 2009 Dec;21(4):585-8. Review.

8.

Medical risk in patients with bipolar disorder and schizophrenia.

Newcomer JW.

J Clin Psychiatry. 2006;67 Suppl 9:25-30; discussion 36-42. Review.

9.

Associations between bipolar disorder and metabolic syndrome: A review.

Taylor V, MacQueen G.

J Clin Psychiatry. 2006 Jul;67(7):1034-41. Review.

PMID:
16889445
10.

Schizophrenia and increased risks of cardiovascular disease.

Hennekens CH, Hennekens AR, Hollar D, Casey DE.

Am Heart J. 2005 Dec;150(6):1115-21. Review.

PMID:
16338246
11.

The effects of undertreated chronic medical illnesses in patients with severe mental disorders.

Fagiolini A, Goracci A.

J Clin Psychiatry. 2009;70 Suppl 3:22-9. doi: 10.4088/JCP.7075su1c.04. Review.

12.

Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.

Misra M, Papakostas GI, Klibanski A.

J Clin Psychiatry. 2004 Dec;65(12):1607-18; quiz 1590, 1760-1. Review.

PMID:
15641865
13.

Antipsychotic medications: metabolic and cardiovascular risk.

Newcomer JW.

J Clin Psychiatry. 2007;68 Suppl 4:8-13. Review.

14.

Metabolic and lifestyle issues and severe mental illness--new connections to well-being?

[No authors listed]

J Psychopharmacol. 2005 Nov;19(6 Suppl):188-22. No abstract available.

PMID:
19886294
15.

Physical health management in psychiatric settings.

De Hert M, van Winkel R, Silic A, Van Eyck D, Peuskens J.

Eur Psychiatry. 2010 Jun;25 Suppl 2:S22-8. doi: 10.1016/S0924-9338(10)71702-8. Review.

PMID:
20620882
16.

Schizophrenia and obesity: impact of antipsychotic medications.

Wirshing DA.

J Clin Psychiatry. 2004;65 Suppl 18:13-26. Review.

17.

Medical comorbidity in bipolar disorder: re-prioritizing unmet needs.

McIntyre RS, Soczynska JK, Beyer JL, Woldeyohannes HO, Law CW, Miranda A, Konarski JZ, Kennedy SH.

Curr Opin Psychiatry. 2007 Jul;20(4):406-16. Review.

PMID:
17551358
18.

Physical health and schizophrenia.

Mitchell AJ, Malone D.

Curr Opin Psychiatry. 2006 Jul;19(4):432-7. Review.

PMID:
16721177
19.

[Severe depression : morbidity-mortality and suicide].

Hardy P.

Encephale. 2009 Dec;35 Suppl 7:S269-71. doi: 10.1016/S0013-7006(09)73484-0. Review. French.

PMID:
20141785
20.

Medical co-morbidity risk factors and barriers to care for people with schizophrenia.

Muir-Cochrane E.

J Psychiatr Ment Health Nurs. 2006 Aug;13(4):447-52. Review.

PMID:
16867129

Supplemental Content

Support Center